Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

[Effect of CD40 blockade on acute renal graft rejection in rats].

Shi XH, Liu XY, Sun XY, Zhao M.

Nan Fang Yi Ke Da Xue Xue Bao. 2011 Dec;31(12):2085-6. Chinese.

2.

In vivo therapeutic efficacy of intra-renal CD40 silencing in a model of humoral acute rejection.

Ripoll E, Pluvinet R, Torras J, Olivar R, Vidal A, Franquesa M, Cassis L, Cruzado JM, Bestard O, Grinyó JM, Aran JM, Herrero-Fresneda I.

Gene Ther. 2011 Oct;18(10):945-52. doi: 10.1038/gt.2011.39. Epub 2011 Apr 7.

PMID:
21472009
3.

A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.

Yuan X, Dong VM, Coito AJ, Waaga AM, Salama AD, Benjamin CD, Sayegh MH, Chandraker A.

Transplantation. 2002 Jun 15;73(11):1736-42.

PMID:
12084995
5.

Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograft recipients.

Cho CS, Burkly LC, Fechner JH Jr, Kirk AD, Oberley TD, Dong Y, Brunner KG, Peters D, Tenhoor CN, Nadeau K, Yagci G, Ishido N, Schultz JM, Tsuchida M, Hamawy MM, Knechtle SJ.

Transplantation. 2001 Aug 27;72(4):587-97.

PMID:
11544416
6.

Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.

Guillonneau C, Aubry V, Renaudin K, Séveno C, Usal C, Tezuka K, Anegon I.

Transplantation. 2005 Jul 27;80(2):255-63. Erratum in: Transplantation. 2005 Aug 27;80(4):545. Corrected and republished in: Transplantation. 2005 Aug 27;80(4):546-54.

PMID:
16041272
7.

Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.

Guillonneau C, Aubry V, Renaudin K, Séveno C, Usal C, Tezuka K, Anegon I.

Transplantation. 2005 Aug 27;80(4):546-54.

PMID:
16220623
8.

A novel, blocking, Fc-silent anti-CD40 monoclonal antibody prolongs nonhuman primate renal allograft survival in the absence of B cell depletion.

Cordoba F, Wieczorek G, Audet M, Roth L, Schneider MA, Kunkler A, Stuber N, Erard M, Ceci M, Baumgartner R, Apolloni R, Cattini A, Robert G, Ristig D, Munz J, Haeberli L, Grau R, Sickert D, Heusser C, Espie P, Bruns C, Patel D, Rush JS.

Am J Transplant. 2015 Nov;15(11):2825-36. doi: 10.1111/ajt.13377. Epub 2015 Jul 2.

PMID:
26139432
9.

4D11: The Second Mouse?

Kirk AD.

Am J Transplant. 2009 Aug;9(8):1701-2. doi: 10.1111/j.1600-6143.2009.02749.x. No abstract available.

10.
11.

Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants.

Qian Y, Boisgerault F, Benichou G, Dana MR.

Invest Ophthalmol Vis Sci. 2001 Apr;42(5):987-94.

PMID:
11274076
12.

Blockade of CD40-CD154 at the time of donor-specific blood transfusion does not lead to prolonged kidney allograft survival in nonhuman primates.

Ringers J, Haanstra KG, Kroczek RA, Kliem K, Kuhn EM, Wubben J, Ossevoort MA, Volk HD, Jonker M.

Transplantation. 2002 Mar 27;73(6):862-6.

PMID:
11923684
14.

A human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys: induction and maintenance therapy.

Aoyagi T, Yamashita K, Suzuki T, Uno M, Goto R, Taniguchi M, Shimamura T, Takahashi N, Miura T, Okimura K, Itoh T, Shimizu A, Furukawa H, Todo S.

Am J Transplant. 2009 Aug;9(8):1732-41. doi: 10.1111/j.1600-6143.2009.02693.x. Epub 2009 Jun 10.

15.

Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.

Lu L, Li W, Fu F, Chambers FG, Qian S, Fung JJ, Thomson AW.

Transplantation. 1997 Dec 27;64(12):1808-15.

PMID:
9422424
16.

Blockade of 4-1BB/4-1BB ligand interactions prevents acute rejection in rat liver transplantation.

Qin L, Guan HG, Zhou XJ, Yin J, Lan J, Qian HX.

Chin Med J (Engl). 2010 Jan 20;123(2):212-5.

17.

The efficacy of CD40 ligand blockade in discordant pig-to-rat islet xenotransplantation is correlated with an immunosuppressive effect of immunoglobulin.

Wennberg L, Goto M, Maeda A, Song Z, Benjamin C, Groth CG, Korsgren O.

Transplantation. 2005 Jan 27;79(2):157-64.

PMID:
15665763
18.

Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient mice.

Corbascio M, Mahanty H, Osterholm C, Qi Z, Pearson TC, Larsen CP, Freise CE, Ekberg H.

Transplantation. 2002 Jul 15;74(1):35-41.

PMID:
12134096
19.

Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates.

Elster EA, Xu H, Tadaki DK, Montgomery S, Burkly LC, Berning JD, Baumgartner RE, Cruzata F, Marx R, Harlan DM, Kirk AD.

Transplantation. 2001 Nov 15;72(9):1473-8.

PMID:
11707732
20.

Gene transfer of human CD40Ig does not prevent rejection in a non-human primate kidney allotransplantation model.

Angin M, Poirier N, Dilek N, Le Guiner C, Toromanoff A, Blancher A, Cherel Y, Deschamps JY, Tillou X, Renaudin K, Minault D, Hervouet J, Blancho G, Vanhove B, Anegon I, Le Mauff B.

Transpl Immunol. 2012 Dec;27(4):139-45. doi: 10.1016/j.trim.2012.10.004. Epub 2012 Oct 23.

PMID:
23098770
Items per page

Supplemental Content

Write to the Help Desk